Geriatric assessment and management: is decreasing treatment toxicity good enough?
- PMID: 37949100
- PMCID: PMC11032707
- DOI: 10.1093/jnci/djad207
Geriatric assessment and management: is decreasing treatment toxicity good enough?
Conflict of interest statement
KPL has served as a consultant for Pfizer and Seagen and has received honoraria from Pfizer. SGM has no disclosures.
Comment on
-
Effectiveness of geriatric assessment and management in older cancer patients: a systematic review and meta-analysis.J Natl Cancer Inst. 2023 Dec 6;115(12):1483-1496. doi: 10.1093/jnci/djad200. J Natl Cancer Inst. 2023. PMID: 37738290
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical